Influenza

        在即将过去的一年里公众已经通过全球流行的SARS、生物恐怖主义的威胁、西奈病毒的增殖和人感染猴痘病毒敏锐地认识到感染性疾病的威胁。现在一种古老的疾病－－流行性感冒正在重新抬头。尽管大多数流感是一种自限性疾病,但是仍然有一部分会产生巨大的经济损失。自从40年前金刚烷胺问世以来，对于流感的控制鲜有进展。在过去的十年，已经积累的证据表明灭活疫苗有保护作用而且活流感病毒疫苗对儿童有效且安全。尽管疫苗技术、流感测试辅助个体诊断、识别病毒传播、优化临床管理的技术有许多新的进展，出现禽流感病毒感染人类以及SARS的全球流行都在提醒我们人类面临流行病时的脆弱。进一步提高对人类和动物的监测、寻找免疫接种的新方法、增加使用对抗流感爆发的疫苗和抗病毒药物，都是减少全球流感爆发的必要方法。CMBI为大家准备了一期关于流行性感冒的特别报道。 更多文献敬请查阅CMBI的文献查询。

• Influenza
  
• Are We Ready for Pandemic Influenza?
  
• Influenza and Cardiovascular Disease A New Opportunity for Prevention and the Need for Further Studies
  
• Recent Advances In The Discovery And Development Of Anti-Influenza Drugs
  
• Influenza Vaccination For Healthy Children
  
• Treatment Of Epidemic And Pandemic Influenza With Neuraminidase And M2 Proton Channel Inhibitors
  
• Therapy-Neuraminidase Inhibitors For The Treatment And Prevention Of Influenza
  
• Therapy-A Designer Drug Against Influenza-The Na Inhibitor Oseltamivir
  
• Sars-Pandemic Influenza And Sars Vaccination
  
• Sars-Old Drugs For-New Bug-Influenza, Hiv Drugs Enlisted To Fight Sars
  
• Respiratory Infections-Caused By Non-Typeable Haemophilus Influenzae
  
• Recent Advances In The Chemistry Of Parainfluenza-1 (Sendai) Virus Inhibitors
  
• Rapid Diagnostic Tests For Influenza
  
• Influenza Virus And Cns Manifestations
  
• Influenza-Vaccinations
  
• Virus Infection And Apoptosis-Influenza Virus Induction Of Apoptosis By Intrinsic And Extrinsic Mechanisms
  
• Zanamivir In The Treatment Of Influenza
  
• Sars-Is Sars Masking An Influenza Threat
  
• Two Aromatic Residues in the PB2 Subunit of Influenza A RNA Polymerase Are Crucial for Cap Binding
  
• vaccine-Antibody response to influenza infection of mice
  
• SARS-The treatment of influenza with antiviral drugs
  
• antiviral-The role of antivirals in the control of influenza
  
• antiviral-The potential use of influenza virus as an agent for bioterrorism
  
• antiviral-Influenza-virus-induced signaling cascades-targets for antiviral therapy
  
• The treatment of influenza with antiviral drugs;
  
• The treatment of influenza with antiviral drugs
  
• Selective incorporation of influenza virus RNA segments into virions
  
• Reduction of the influenza burden in children
  
• Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents
  
• Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression
  
• Influenza-virus-induced signaling cascades-targets for antiviral therapy
  
• Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses
  
• Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes-
  
• Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes
  
• Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus
  
• Evaluation of a rapid test (QuickVue) compared with the shell vial assay for detection of influenza virus clearance after antiviral treatment
  
• Development of a novel influenza A antiviral assay
  
• Defective influenza A virus generated entirely from plasmids-its RNA is expressed in infected mouse lung and modulates disease
  
• Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid test results
  
• Cost-effectiveness of newer treatment strategies for influenza
  
• Antiviral drugs-Treatment of influenza and respiratory syncytial virus infections
  
• antiviral-Effect of antioxidants on apoptosis induced by influenza virus infection
  
• Molecular diagnosis of influenza
  
• Generation of influenza A virus from cloned cDNAs
  
• Ecological and immunological determinants of influenza evolution
  
• RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription
  
• Influenza virosomes
  
• Evidence-Based-inactivated vaccines provide the greatest protection against influenza in healthy people
  
• Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques
  
• Novel approaches in the development of immunopotentiating reconstituted influenza virosomes
  
• PNEUMOCOCCAL AND INFLUENZA VACCINATION
  
• The treatment of influenza with antiviral drugs
  
• treatment of influenza with antiviral drugs
  
• Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice
  
• Molecular diagnosis of influenza
  
• GENETICS OF INFLUENZA VIRUSES
  
• Peramivir (BCX-1812, RWJ-270201)-potential new therapy for influenza
  
• Neuraminidase inhibitors for the treatment and prevention of influenza
  
• Recent advances in the discovery and development of anti-influenza drugs
  
• Zanamivir and oseltamivir-two new options for the treatment and prevention of influenza
  
• Laboratory diagnosis of influenza virus infection
  
• Laboratory diagnosis of influenza virus infection
  
• Influenza vaccination for healthy children
  
• Influenza vaccines-present and future
  
• Mechanisms of cell entry by influenza virus
  
• Cytokine receptors, signaling pathways and viruses-Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression
  
• Cold-adapted influenza vaccines
  
• Association Between Influenza Vaccination and Reduced Risk of Brain Infarction
  
• Association Between Influenza Vaccination and Reduced Risk of Brain Infarction
  
• Influenza-Will New Diagnostic Tests and Antiviral Drugs Make a Difference
  
• Prevention, diagnosis, and treatment of influenza-current and future options
  
• Influenza vaccination in old age
  
• Influenza-Prospects for Control
  
• Antisense therapy of influenza
  
• Pharmacotherapy-Zanamivir in the Treatment and Prevention of Influenza
  
• The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus,Implications for peptide vaccination
  
• Immunoadjuvant activity of interferon-γ-liposomes co-administered with influenza vaccines
  
• The pathogenesis of influenza in humans
  
• Control of influenza. Public health policies
  
• public healthConsiderations for adding pneumonia and influenza vaccines to public health programmes
  
• Zanamivir and oseltamivir- two new options for the treatment and prevention of influenza -drug
  
• Global Epidemiology of Influenza
  
• Medical Progress- Respiratory Syncytial Virus and Parainfluenza Virus
  
• New Options for the Prevention of Influenza
  
• Medical Progress-Is It Time to Give Influenza Vaccine to Healthy Infants
  
• Medical Progress-Influenza in the Family
  
• Influenza in the Family
  
• High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection
  
• A novel bioadhesive intranasal delivery system for inactivated influenza vaccines
  
• Influenza- Prospects for Control
  
• Neuraminidase Inhibitors in the Treatment of Influenza A and B - Overview and Case Reports
  
• Global Epidemiology of Influenza
  
• Intranasal immunization with inactivated influenza vaccine
  
• influenza
  
• Influenza Control#151Unfinished Business
  
• Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction
  
• Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme